Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04684108
Title SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hangzhou Sumgen Biotech Co., Ltd.

multiple myeloma

hematologic cancer

chronic lymphocytic leukemia

non-Hodgkin lymphoma

Hodgkin's lymphoma



Age Groups: adult | senior
Covered Countries

No variant requirements are available.